Medical Information

The use of Vuity eye drops (pilocarpine) for the treatment of presbyopia requires strict adherence to the twice daily medication regimen, and can be optimized with a healthy lifestyle. The following provides a detailed explanation from three aspects: standard usage, adjustment for special populations, and lifestyle management, to help patients use the drug safely and effectively.

1. Standard usage and dosage

(1) Conventional dosage: twice a day (with an interval of about 12 hours), 1 drop per time, recommended for use in the morning and noon for optimal daytime visual improvement in the affected eye.

(2) Administration method: Close the eyes for 1 minute after dripping, gently press the lacrimal sac area for 2 minutes to reduce systemic absorption, and avoid bottle mouth contact with eyelids to prevent contamination.

2. Adjustment for special populations

(1) Liver dysfunction: Mild to moderate without adjustment, severe patients (Child Pugh C grade) need to be monitored for cholinergic side effects.

(2) Elderly: Patients over 65 years old do not need to reduce their dosage initially, but they need to be closely monitored to regulate adverse reactions such as spasms.

3. Cooperate with a healthy lifestyle

(1) Eye hygiene: Avoid prolonged use of electronic screens, gaze for 20 seconds every 20 minutes, and use artificial tears to alleviate dry eye symptoms.

(2) Dietary management: Reduce the impact of high-fat diet on drug absorption, and supplement vitamins A and D in moderation to promote eye surface health.

4. Key points of synergy between medication and daily life

(1) Exercise timing: Avoid vigorous exercise within 1 hour after administration to prevent sweat from washing the medication around the eyes.

(2) Sleep management: The last medication should be taken no later than 3pm to avoid night time pupil constriction affecting dark vision.

5. Monitoring and recording

(1) Self observation: Establish a medication diary to record the duration of visual improvement and whether there are adverse reactions such as headaches and eye pain.

(2) Regular follow-up: Check intraocular pressure, anterior chamber depth, and retinal condition every 3 months to assess long-term medication safety.